(3R,4S,5R,6R)-6-[[(2S,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

Metabolite details

Identifier

FBJQEBRMDXPWNX-MEGYGSNGSA-N

InChI Key

FBJQEBRMDXPWNX-MEGYGSNGSA-N

IUPAC name

Preferred name

(3R,4S,5R,6R)-6-[[(2S,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-[[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxymethyl]oxane-2,3,4,5-tetrol

INN name

—

Synonym

alpha-D-galacto-hexopyranosyl-(1->6)-alpha-D-galacto-hexopyranosyl-(1->6)-D-galacto-hexopyranose

ChEBI

CHEBI:150061

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Unknown Metabolite Annotation in Mouse Aging using Ion Mobility Collision Cross-Section Atlas (AllCCS)

Observed in differential profiles

• 36_week_vs_104_week